Supporting you in understanding and prioritizing evidence requirements and planning for generating compelling evidence to support payer decision-making.
Quality evidence is paramount in translating the value of your asset into the right price. We help you develop an impactful evidence generation plan that underpins your value strategy and resonates with payers across geographies.
What we do
Inbeeo’s goal is to put strategy back into market access. An important part of that process is turning data – from secondary or primary research, databases, real-world evidence, or anywhere else – into insights which help you:
Create a payer-relevant TPP and value proposition, including a supporting evidence base
Develop a briefing book for early scientific advice
Identify payer needs and preferences to prioritize evidence requirements in different geographies
Critically appraise and provide recommendations to strengthen health economic models
Plan for generating a robust and compelling set of evidence over time in support of your market access strategy
How we do it
Data analysis and actionable insight recommendations
Landscape analysis for indications, HTA decisions, HEOR data and more
Analysis of access policy trends and implications
Analogue analysis
In-depth qualitative research
Strengthening RWE and HEOR functions
The tools we use
Our proprietary custom value assessment framework allows our customers to identify data generation strategies which maximize the value of their asset, highlighting key value drivers and domains.
